About
Technology
Issues
FAQ
Links
Official Page
Interleukin-6 as one of the potential mediators of immune-related adverse events in non-small cell lung cancer patients treated with immune checkpoint blockade: evidence from a case report
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.